• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
XGN

XGN

Exagen Inc.

NASDAQHealthcareMedical - Diagnostics & ResearchUS

USD4.54

-0.28 (-5.81%)

Rating:C-

Company Profile

CEO

John Aballi

IPO Date

2019-09-19

Sector

Healthcare

Industry

Medical - Diagnostics & Research

Exchange

NASDAQ

Country

US

Market Metrics

Open

$4.86

Prev. Close

$4.82

Day Low

$4.49

Day High

$4.94

52W Low

$2.59

52W High

$12.23

Market Cap

$0.11B

Volume

0.28M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

25.0%

Avg Negative

2.4%

Avg Neutral

72.4%

News Feed

Exagen Appoints Ana Hooker to Board of Directors

GlobeNewsWire·7/30/2021·↑ positive

Exagen Inc. to Participate in the Canaccord Genuity 41st Annual Growth Conference

GlobeNewsWire·7/29/2021·↑ positive

AVISE® Lupus Test Demonstrates Statistically Significant Clinical Utility in Achieving a Definitive SLE Diagnosis and Positively Impacts Treatment Decisions

GlobeNewsWire·7/13/2021·↑ positive

Exagen Elects Frank Stokes to Board of Directors

GlobeNewsWire·6/18/2021·↑ positive

Exagen Inc. to Participate in the William Blair 41st Annual Growth Stock Conference

GlobeNewsWire·5/24/2021·↑ positive

Exagen Inc. (XGN) CEO Ron Rocca on Q1 2021 Results - Earnings Call Transcript

Seeking Alpha·5/11/2021·↓ negative

Exagen Inc. Reports First Quarter 2021 Results

GlobeNewsWire·5/11/2021·↑ positive

Exagen Inc., Allegheny Health Network Research Institute and AHN Autoimmunity Institute Announce Collaboration to Develop Novel Patented Biomarkers into Clinical Diagnostic Tests

GlobeNewsWire·5/4/2021·↑ positive

Exagen Announces New Campaign and Initiatives for Lupus Awareness Month

GlobeNewsWire·5/3/2021·↑ positive

Exagen to Announce First Quarter 2021 Financial Results on May 11, 2021

GlobeNewsWire·4/27/2021·↓ negative